Navigation Links
Watch-PAT 100

ProductsWatch-PAT 100
Company Itamar Medical Ltd.
Item Watch-PAT 100
Features 
  • Diagnosis, treatment assessment and follow-up of sleep-related breathing disorders
  • Minimal sleep interference
  • Non-invasive finger probes pose no patient risk
  • Ambulatory, comfortable and convenient for unattended home use
  • Advanced automatic analysis and digital signal processing algorithms
  • Automatic scoring presented in a comprehensive report
  • Single button operation
  • Records and stores data on removable media
Description The Watch-PAT 100 provides a new screening, diagnostic, treatment assessment and patient follow-up possibilities in the medical management of sleep-related breathing disorders. The Watch-PAT 100 is designed to fulfill the unmet need for an ambulatory, reliable, patient friendly diagnostic evaluation tool that is accessible to the great number of OSA sufferers, and to the equally important need for a cost effective means for follow up of treated patients. The Watch-PAT 100 opens new clinical avenues for the practice of sleep medicine.

The Watch-PAT 100 is a self-contained device that is worn on the wrist and uses a non-invasive finger mounted pneu-optical probe to measure the PAT signal. The recorded signals are stored in a removable memory card in the device to be downloaded to a computer for automatic analysis utilizing proprietary algorithms. In addition to the PAT Signal, the Watch-PAT 100 records oxygen saturation and actigraphy. A fourth channel, pulse rate, is derived from the PAT Signal.

The Watch-PAT 100 offers physicians and the millions of undiagnosed sufferers of obstructive sleep apnea a new option for ambulatory, patient-friendly, unattended first line diagnostic evaluation of sleep related breathing disorders.

Info Itamar Medical Ltd.
Customer Service: (800) 206-6952
Web site: http://www.itamar-medical.com

Related medicine products :

1. I-PTH ELISA Test
For the qualitative detection of group A streptococcal antigen from throat swabs....
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
Medicine Products:
(Date:5/24/2016)... ... May 24, 2016 , ... Clarion Safety ... safety labels , has been featured in the National Electrical Manufacturers Association’s ... e-newsletter provides electroindustry professionals with manufacturer, regulatory, and standardization news. The publication is ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... disease research and education, today announced that it has named Scott Santarella as ... Bonnie J. Addario Lung Cancer Foundation (ALCF) in San Francisco, where he successfully ...
(Date:5/24/2016)... ... 24, 2016 , ... After graduating from Cornell, author Joshua Alexander ... on medication, living on Social Security disability and staying in a group home. In ... It!” (published by Balboa Press), Alexander shares how he was finally able to heal ...
(Date:5/24/2016)... ... ... PhysicianOne Urgent Care, advocators in helping their patients lead the healthiest lives possible, updates ... spring. , The official tick season kicks off in May across the states ... themselves to their prey while they feed off their blood. Like other similar biting ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts , ... Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was designed ... something special for this often overlooked neighborhood. Located at 609 E. 6th Street, ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016  NxStage Medical, Inc. (Nasdaq: ... on advancing renal care, today announced that Jeffrey ... in the following schedule of investor conferences. Where applicable, ... at http://ir.nxstage.com/ .   ... Conference NY, NY           Friday, June 10, 2016 1:30 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
(Date:5/24/2016)... Marziani has joined VMS BioMarketing as senior vice president of sales, announced Andrea ... Marziani will lead the company,s business development and sales team, exploring new opportunities for ... - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
Breaking Medicine Technology: